Novo Nordisk of North America, Inc. v. Genentech, Inc.
District Court, S.D. New York
1Opinion of the Court
OPINION
MOTLEY, District Judge.
GENENTECH’S MOTION TO TRANSFER OR STAY
Both Novo Nordisk and Genenteeh are involved in the business of genetically-engineered pharmaceutical products. Novo Nor-disk is waiting to get FDA approval to be able to sell Norditropin, genetically-engineered human growth hormone, inside of the United States. Genenteeh owns some U.S. patents concerning the production of human growth hormone.
In March 1993, Genenteeh brought an action against Novo Nordisk before the U.S. International Trade Commission (ITC) alleging that Novo Nordisk’s product, Norditro-pin, infringed four…
2Cases cited5 opinions
- Kerotest Manufacturing Co. v. C-O-Two Fire Equipment Co.Supreme Court of the United States · 1952
- Genentech, Inc. v. Eli Lilly and Company, and the Regents of the University of CaliforniaCourt of Appeals for the Federal Circuit · 1993
- William Gluckin & Co., Inc. v. International Playtex CorporationCourt of Appeals for the Second Circuit · 1969
- 800-Flowers, Inc. v. Intercontinental Florist, Inc.District Court, S.D. New York · 1994
- William Gluckin & Co. v. International Playtex Corp.District Court, S.D. New York · 1968
3Cited by5 opinions
- Everest Capital Ltd. v. Everest Funds Management, L.L.C.District Court, S.D. New York · 2002
- Charter Oak Fire Insurance v. Broan-Nutone, L.L.C.District Court, D. Connecticut · 2003
- Dupont Pharmaceuticals Company v. Sonus Pharmaceuticals, Inc.District Court, D. Massachusetts · 2000
- Nuss v. Guardian Life Insurance Company of AmericaDistrict Court, S.D. New York · 2021
- Nuss v. Guardian Life Insurance Company of AmericaDistrict Court, N.D. Georgia · 2021